Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients.
暂无分享，去创建一个
E. Martinelli | F. Ranelletti | G. Scambia | G. Ferrandina | C. Ferlini | S. Mozzetti | D. Gallo | P. Concolino | G. Raspaglio | Flavia Filippetti | S. Prislei